OVERVIEW
Sandra Eley appeals the district court’s summary judgment dismissal of her action for medical benefits against the Boeing Company and King County Medical Blue Shield pursuant to 29 U.S.C. § 1132 of ERISA.
ISSUES
(1) Whether the district court erred in reviewing the plan administrator’s interpretation of a plan term for abuse of discretion.
(2) Was the plan administrator’s interpretation of “diagnostic test” an abuse of discretion?
FACTS
Boeing sponsors and funds an ERISA ■ employee welfare benefit plan. The Welfare Benefit Plans Committee is the plan administrator. Boeing employs King County Medical Blue Shield as contract administrator. The plan is provided pursuant to collective bargaining agreements between Boeing and its salaried employees.
Shortly before she became covered under Boeing’s health plan, Eley had a Pap test which resulted in a Class II-atypical finding. A Class-II result indicates that an abnormality, such as cervical cancer, may be present. Shortly after she became covered under the plan, Eley had a biopsy which indicated cervical cancer. She thereafter had a hysterectomy.
After her surgery, Eley submitted a claim to Blue Shield for reimbursement. Blue Shield denied the claim because it determined that the cancer was an illness for which Eley had received a diagnostic test (the Pap test) during the three-month period before her coverage became effective. Eley claimed that a Pap test was not a diagnostic test. Blue Shield reviewed the issue with its medical staff and reaffirmed its decision. Eley then appealed to Boeing’s Welfare Benefit Plans Committee, *278 submitting declarations of two physicians who stated that Pap tests were not diagnostic tests. Blue Shield submitted the opinion of its medical staff and definitions from Webster’s Dictionary and the Merck Manual of Diagnosis and Therapy. The Committee concluded that Blue Shield had used proper procedures in reviewing Eley’s claim and that it had properly interpreted the plan provision.
Eley brought suit in the district court, which granted summary judgment for the defendant. It found no abuse of discretion in the Committee’s interpretation of the plan.
■DISCUSSION
I. Standard of Review of Administrator’s Determination
Eley argues that the district court erred in reviewing the administrator’s determination for abuse of discretion rather than de novo. We hold that the district court applied the proper standard of review.
In
Firestone Tire & Rubber Co. v. Bruch,
The provisions of the Boeing plan
2
are comparable to plan provisions we have previously held to confer discretion.
See, e.g., Dytrt v. Mountain State Tel. & Tel. Co.,
The
Bruch
Court also stated that if a plan bestows discretionary authority upon an administrator who is operating
*279
under a conflict of interest, the conflict must be considered in determining whether an abuse of discretion has occurred.
Id.
at 115,
II. Boeing’s Determination that a Pap Test Is a Diagnostic Test
The plan excludes “expenses during the first twelve months of a person’s coverage to the extent that they are in connection with a preexisting condition.” A preexisting condition is defined as “any illness ... whether or not diagnosed, for which a person has received medical treatment, consultation, a diagnostic test or prescribed medicines during the three-month period before his or her coverage becomes effective.” Blue Shield interpreted “diagnostic test” to include Pap tests and therefore found that expenses related to Eley’s cervical cancer surgery were excluded from coverage.
“[T]rustees abuse their discretion if they render decisions without any explanation, or construe provisions of the plan in a way that clearly conflicts with the plain language of the plan.”
Johnson v. Trustees of the Western Conf. of Teamsters Pension Trust Fund,
Eley failed to meet her burden under the
Johnson
test. We reject her assertion that the English language meaning of “diagnostic” supports her interpretation of the term rather than Boeing’s. We recognize the correctness of her position that screening tests like the Pap test indicate the
absence
of disease while a diagnosis is defined as “the art or act of recognizing the
presence
of disease.”
Webster’s New International Dictionary
(2d ed. 1950) (emphasis added). Screening tests also recognize, however, the
possible
presence of disease, therefore fitting within the definition of diagnosis. Although a layperson would probably not consider herself “diagnosed” with cervical cancer upon receiving a Class II-atypical finding from her Pap test, the plan specifically excludes from coverage conditions
not diagnosed
for which a “diagnostic test” has been given. Boeing’s affidavits that a Pap test is referred to as a diagnostic test by at least some of the medical academic community are not refuted. We cannot say that the interpretation given to “diagnostic test” by Blue Shield and approved by Boeing clearly conflicts with the plain language of the plan.
Cf. Jones,
Kunin v. Benefit Trust Life Ins. Co.,
This case differs significantly from
Ku-nin
in two respects. The present plan, unlike that in
Kunin,
is the result of a collective bargaining agreement.
See id.
at 540 (distinguishing earlier Ninth Circuit cases holding
contra proferentem
inapplicable to ERISA cases where the ambiguous policy language was a result of a collective bargaining agreement). Secondly, in contrast to the insurance policy purchased by the employer in
Kunin,
the Boeing plan is self-funded. Although
contra proferen-tem
is strictly applied in the interpretation of insurance contracts, it is not automatically or universally applied to other contracts, especially those that result from arms-length bargaining by parties of equal power, as in the case of collective bargaining agreements.
See Taylor v. Continental Group Change in Control Severance Pay Plan,
The parties shall bear their own costs.
AFFIRMED.
Notes
. In
Madden v. ITT Long Term Disability Plan,
. The Company shall determine the eligibility of a person for benefits under the plan, pursuant to the terms and conditions specified in Appendix A to this Agreement unless other procedures are agreed to by the Company and the service representative.
CR 11, Exh. B at ¶ 3.2.1.
The Service Representative will provide to the company, upon request, copies of the'claim records of rejected claims, and will abide by the Company’s decision thereon.
Id. at ¶ 3.4.1.
The Company retains final authority and responsibility for the Plan and its operation.
Id. at ¶ 3.4.4.
